Letters to the Editor

Flow cytometric detection of the thymic stromal lymphopoietin receptor reliably identifies CRLF2-rearranged BCR::ABL1-like acute lymphoblastic leukemia

Department of Hematology, Oncology and Cancer Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität and Humboldt-Universität zu Berlin, Berlin
Department of Internal Medicine II (Hematology/Oncology), University Hospital Schleswig-Holstein, Kiel
Department of Internal Medicine II (Hematology/Oncology), University Hospital Schleswig-Holstein, Kiel
Department of Internal Medicine II (Hematology/Oncology), University Hospital Schleswig-Holstein, Kiel
Department of Internal Medicine II (Hematology/Oncology), University Hospital Schleswig-Holstein, Kiel
Department of Hematology, Oncology and Cancer Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität and Humboldt-Universität zu Berlin, Berlin, Germany; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité – Universitätsmedizin Berlin, Berlin
Department of Hematology, Oncology and Cancer Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität and Humboldt-Universität zu Berlin, Berlin
Department of Medicine II, Hematology/Oncology, Goethe University Frankfurt, University Hospital, Frankfurt
Department of Hematology, Oncology and Cancer Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität and Humboldt-Universität zu Berlin, Berlin, Germany; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité – Universitätsmedizin Berlin, Berlin, Germany; National Center for Tumor Diseases (NCT), partner site Berlin, a partnership between DKFZ and Charité – Universitätsmedizin Berlin, Berlin, Germany; Cluster of Excellence ImmunoPreCept, Charité - Universitätsmedizin Berlin, Berlin, Germany; Max-Delbrück-Center for Molecular Medicine, Berlin
Department of Hematology, Oncology and Cancer Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität and Humboldt-Universität zu Berlin, Berlin, Germany; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité – Universitätsmedizin Berlin, Berlin
Haematologica Early view Nov 5, 2026 https://doi.org/10.3324/haematol.2026.301773